aTYR Pharma CFO reports rights to 88,000 shares
The RSUs vest in three equal annual installments beginning January 9, 2027, and will fully vest January 9, 2029.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
aTYR Pharma CFO Brandon Yaras reports four direct employee stock option positions and 88,000 restricted stock units (RSUs); the remarks state that no securities are beneficially owned. The options relate to 70,000 shares at a $3.4800 exercise price, expiring May 10, 2032; 28,450 shares at $2.1950, expiring February 16, 2033; 55,000 shares at $1.5000, expiring January 5, 2034; and 84,142 shares at $3.7400, expiring January 8, 2035. Each RSU represents a contingent right to receive one common share.
Insider Trade Summary
5 transactions reported
Mixed
5 txns
Insider
Yaras Brandon
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Employee Stock Option (right to buy) F1 | -- | -- | -- |
| holding | Employee Stock Option (right to buy) F2 | -- | -- | -- |
| holding | Employee Stock Option (right to buy) F3 | -- | -- | -- |
| holding | Employee Stock Option (right to buy) F4 | -- | -- | -- |
| holding | Employee Restricted Stock Unit F6, F5 | -- | -- | -- |
Holdings After Transaction:
Employee Stock Option (right to buy) — 237,592 contracts (Direct);
Employee Restricted Stock Unit — 88,000 contracts (Direct)
Footnotes (6)
- F1. 1/4 of the shares subject to this option vested and became exercisable on May 10, 2023, and the remainder shares vested in 36 equal monthly installments, such that this option became fully exercisable on May 10, 2026. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.
- F2. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 16, 2023, such that this option will be fully exercisable on February 16, 2027. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.
- F3. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning February 5, 2024, such that this option will be fully exercisable on January 5, 2028. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.
- F4. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning February 8, 2025, such that this option will be fully exercisable on January 8, 2029. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.
- F5. The restricted stock unit (RSU) shall vest in three equal annual installments beginning on January 9, 2027, such that the RSUs will fully vest January 9, 2029. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
- F6. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Key Figures
Employee stock option position: 70,000 underlying common shares; $3.4800 exercise price per share
Employee stock option position: 28,450 underlying common shares; $2.1950 exercise price per share
Employee stock option position: 55,000 underlying common shares; $1.5000 exercise price per share
+2 more
5 metrics
Employee stock option position
70,000 underlying common shares; $3.4800 exercise price per share
Expires May 10, 2032
Employee stock option position
28,450 underlying common shares; $2.1950 exercise price per share
Expires February 16, 2033
Employee stock option position
55,000 underlying common shares; $1.5000 exercise price per share
Expires January 5, 2034
Employee stock option position
84,142 underlying common shares; $3.7400 exercise price per share
Expires January 8, 2035
Restricted stock units
88,000 RSUs
Three equal annual vesting installments beginning January 9, 2027
Key Terms
Employee Restricted Stock Unit, accelerated vesting, contingent right, fully exercisable
4 terms
Employee Restricted Stock Unit financial
"Employee Restricted Stock Unit"
accelerated vesting technical
"subject to accelerated vesting upon termination without cause"
A contract feature that makes stock awards, options, or restricted shares become owned or exercisable earlier than the original schedule. It shortens or cancels the waiting period so recipients can sell, transfer, or exercise their equity sooner — think of a timed lock that is unlocked ahead of schedule. It matters to investors because it changes when shares enter the market, who controls them, and how much dilution or ownership concentration happens.
contingent right technical
"Each RSU represents a contingent right to receive one share"
fully exercisable technical
"this option became fully exercisable on May 10, 2026"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When do Brandon Yaras's ATYR RSUs vest?
The 88,000 RSUs vest in three equal annual installments beginning January 9, 2027, and will fully vest January 9, 2029. Each RSU represents a contingent right to receive one share of the issuer's common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
